Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
5.26
+0.04 (0.77%)
At close: May 27, 2026, 4:00 PM EDT
5.30
+0.04 (0.76%)
After-hours: May 27, 2026, 7:54 PM EDT
Minerva Neurosciences Employees
Minerva Neurosciences had 7 employees as of December 31, 2025. The number of employees decreased by 1 or -12.50% compared to the previous year.
Employees
7
Change (1Y)
-1
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$59,296,370
Market Cap
245.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | -1 | -12.50% |
| Dec 31, 2024 | 8 | -1 | -11.11% |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | 0 | - |
| Dec 31, 2021 | 9 | -2 | -18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Fate Therapeutics | 161 |
| LENZ Therapeutics | 152 |
| Entrada Therapeutics | 152 |
| Codexis | 146 |
| Adagene | 128 |
| Alector | 103 |
| Orchestra BioMed Holdings | 86 |
NERV News
- 9 days ago - Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 22 days ago - Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 22 days ago - Minerva Neurosciences Earnings release: Q1 2026 - Filings
- 22 days ago - Minerva Neurosciences Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Minerva Neurosciences Proxy statement: Proxy filing - Filings
- 4 weeks ago - Minerva Neurosciences Proxy statement: Proxy filing - Filings
- 6 weeks ago - Minerva initiated with an Outperform at Citizens - TheFly
- 6 weeks ago - Minerva Neurosciences Proxy statement: Proxy filing - Filings